These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35312116)

  • 61. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.
    Liu X; Hou Y; Wang X; Yu L; Wang X; Jiang L; Yang Z
    Hepatol Int; 2020 Jul; 14(4):567-576. PubMed ID: 32556865
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.
    Qiu J; Yang J; Yu Y; Wang Z; Lin H; Ke D; Zheng H; Li J; Yao Q
    BMC Cancer; 2023 Jun; 23(1):597. PubMed ID: 37380982
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.
    Howell J; Pinato DJ; Ramaswami R; Arizumi T; Ferrari C; Gibbin A; Burlone ME; Guaschino G; Toniutto P; Black J; Sellers L; Kudo M; Pirisi M; Sharma R
    Oncotarget; 2017 May; 8(22):36161-36170. PubMed ID: 28212535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
    Persano M; Rimini M; Tada T; Suda G; Shimose S; Kudo M; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Yoo C; Lonardi S; Stefanini B; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Montes M; Vivaldi C; Soldà C; Hiraoka A; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Burgio V; Della Corte A; Ratti F; De Cobelli F; Aldrighetti L; Scartozzi M; Cascinu S; Casadei-Gardini A
    Oncology; 2023; 101(5):283-291. PubMed ID: 36657420
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer 
Based on Geriatric Nutritional Risk Index].
    Zhang X; Xiong Y; Xu A
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):497-506. PubMed ID: 37653013
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
    Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
    Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]   [Full Text] [Related]  

  • 70. Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.
    Da L; Qu Z; Zhang C; Shen Y; Huang W; Zhang Y; Gu K
    Front Oncol; 2023; 13():1144875. PubMed ID: 37035159
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma.
    Xing M; Li J
    BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
    Zhang Y; Kong FF; Zhu ZQ; Shan HX
    BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy.
    Zhang J; Qin SD; Li Y; Lu F; Gong WF; Zhong JH; Ma L; Zhao JF; Zhan GH; Li PZ; Song B; De Xiang B
    World J Surg Oncol; 2022 Oct; 20(1):346. PubMed ID: 36258212
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors.
    Xiong B; Fu B; Wu Y; Gao F; Hou C
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11607-11617. PubMed ID: 37400572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
    Zhang T; Liu Z; Zhao X; Mao Z; Bai L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
    [No Abstract]   [Full Text] [Related]  

  • 76. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma.
    Wu F; Chen Q; Liu C; Duan X; Hu J; Liu J; Cao H; Li W; Li H
    Cancer Med; 2020 Mar; 9(6):2171-2180. PubMed ID: 31975560
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
    Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
    Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
    Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
    Front Immunol; 2021; 12():691364. PubMed ID: 34248983
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
    Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
    Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.
    Matsumoto T; Kitano Y; Imai K; Kinoshita S; Sato H; Shiraishi Y; Mima K; Hayashi H; Yamashita YI; Baba H
    Surg Today; 2022 Jul; 52(7):1008-1015. PubMed ID: 35083547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.